Genpact (G) is trading higher today as Wall Street sentiment improves following a recent analyst-rating upgrade that highlighted a better earnings outlook and helped attract incremental buying interest. The stock has been under pressure recently, so even modest positive catalysts have had an outsized impact on price action as investors reassess downside risk versus valuation.

Separately, Genpact recently announced a new multi-year agreement with GE HealthCare that expands Genpact’s role supporting equipment financing capabilities using its business-process-as-a-service (BPaaS) operating model. While the analyst action appears to be the immediate spark for today’s move, the GE HealthCare expansion strengthens the broader narrative that Genpact’s digital-led offerings can drive durable, multi-year revenue streams.

The rally comes just days after Genpact touched a 52-week low, making the stock more sensitive to any sign that fundamentals are holding up or that expectations have become too pessimistic. With investors rotating toward names seen as comparatively defensive within technology-enabled services, an upgrade plus visible contract expansion can be enough to trigger a quick repricing.

Key next checks for the move’s durability include follow-through in volume, any additional analyst revisions, and updates on large-client wins in healthcare and other verticals. Traders will also focus on whether management reiterates or tightens its outlook as the company moves closer to its next quarterly report, since confirmation of steady demand would support further multiple recovery.